When do you use immunotherapy with MSI high advanced colorectal cancer?

does it matter whether it is given frontline vs later?

1 Answer

Mednet Member

Medical Oncology · University of Texas MD Anderson Cancer Center

Answered on · Updated on

Based on the available data from the KEYNOTE trials and CheckMate 142, I use immunotherapy in the second-line (or greater) setting. There is no data at this time to support front-line use, so I would only consider that for patients who are not good candidates for combination chemotherapy. KEYNOTE-17...

Join for free or sign in to see the full answer